Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases-Reference-Cited by-同舟云学术

Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases

Published:2015-09-15 Issue:8 Volume:113 Page:1206-1215
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Renaud Stéphane,Falcoz Pierre-Emmanuel,Schaëffer Mickaël,Guenot Dominique,Romain Benoit,Olland Anne,Reeb Jérémie,Santelmo Nicola,Chenard Marie-Pierre,Legrain Michèle,Voegeli Anne-Claire,Beau-Faller Michèle,Massard Gilbert

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2015327.pdf

Reference22 articles.

1. Alamo P, Gallardo A, Di Nicolantonio F, Pavon MA, Casanova I, Trias M, Mangues MA, Lopez-Pousa A, Villaverde A, Vazquez E, Bardelli A, Cespedes MV, Mangues R (2015) Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model. Faseb J 29 (2): 464–476.

2. Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, Flanagan A, Teague J, Futreal PA, Stratton MR, Wooster R (2004) The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91 (2): 355–358.

3. Beau-Faller M, Blons H, Domerg C, Gajda D, Richard N, Escande F, Solassol J, Denis MG, Cayre A, Nanni-Metellus I, Olschwang S, Lizard S, Piard F, Pretet JL, de Fraipont F, Bieche I, de Cremoux P, Rouquette I, Bringuier PP, Mosser J, Legrain M, Voegeli AC, Saulnier P, Morin F, Pignon JP, Zalcman G, Cadranel J (2013) A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting-IFCT/ERMETIC2 project part 1: comparison of testing methods in 20 French Molecular Genetic National Cancer Institute platforms. J Mol Diagn 16 (1): 45–55.

4. Beau-Faller M, Legrain M, Voegeli AC, Guerin E, Lavaux T, Ruppert AM, Neuville A, Massard G, Wihlm JM, Quoix E, Oudet P, Gaub MP (2009) Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping. Br J Cancer 100 (6): 985–992.

5. Bossard N, Velten M, Remontet L, Belot A, Maarouf N, Bouvier AM, Guizard AV, Tretarre B, Launoy G, Colonna M, Danzon A, Molinie F, Troussard X, Bourdon-Raverdy N, Carli PM, Jaffre A, Bessaguet C, Sauleau E, Schvartz C, Arveux P, Maynadie M, Grosclaude P, Esteve J, Faivre J (2007) Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer 43 (1): 149–160.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow adipocytes and lung cancer bone metastasis: unraveling the role of adipokines in the tumor microenvironment;Frontiers in Oncology;2024-03-20

2. Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretability;Experimental & Molecular Medicine;2024-03-04

3. Prognostic value of KRAS G12V mutation in lung adenocarcinoma stratified by stages and radiological features;The Journal of Thoracic and Cardiovascular Surgery;2024-03

4. Fast, sensitive, and specific multiplexed single-molecule detection of circulating tumor DNA;Biosensors and Bioelectronics;2023-12

5. Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial;The Annals of Thoracic Surgery;2023-10